Print Page

给 医 护 专 业 人 员 的 信
 
Third generation aromatase inhibitors (anastrozole, exemestane, letrozole): Assessing the potential risk of tendon disorders (Letter to Healthcare Professionals) (English only)
 
 
 
附件:
  1. Third generation aromatase inhibitors (anastrozole, exemestane, letrozole): Assessing the potential risk of tendon disorders (English only)  
Related Information:
Canada: Summary Safety Review: Third generation aromatase inhibitors (anastrozol... 上载于 2023-01-18
 
back